Health watchdogs have sounded the alarm on a worrying trend: the undue influence of commercial interests on public health policy-making. A recent report by the ethics commission highlights the need for greater transparency in lobbying activities, sparking a chorus of support from leading UK health organisations.
The call to action comes as no surprise to those familiar with the complex web of relationships between industry lobbyists and policymakers. Caroline Cerny, Deputy Chief Executive of Action on Smoking and Health, points out that "there's extensive global evidence showing how firms profiting from tobacco, alcohol, and unhealthy food have consistently sought to undermine public health policies." Professor Sir Ian Gilmore, Chair of the Alcohol Health Alliance, adds: "This isn't just about the money; it's about lives. Lives lost to preventable diseases fuelled by the interests of big business."
According to a report from the National Audit Office (NHS, 2022), approximately 30% of NHS spending is attributed to conditions linked to unhealthy lifestyle choices, such as obesity and smoking-related illnesses. The true cost of these lobbying efforts, however, remains shrouded in secrecy.
The lack of transparency allows commercial interests to operate behind closed doors, making it challenging for policymakers to identify conflicts of interest. As Katharine Jenner, Executive Director of the Obesity Health Alliance, notes: "The public has a right to know who's pulling the strings and how their efforts are shaping policy decisions that affect our health."
Implementing greater transparency would not only hold lobbyists accountable but also give policymakers a clearer picture of what's at stake. It's a vital step towards safeguarding public health and ensuring that policies are developed in the best interests of citizens, rather than corporate profits.